Taiwan · Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 8.63 billion. The enterprise value is 7.75 billion.
| Market Cap | 8.63B |
| Enterprise Value | 7.75B |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 4.21% |
| Owned by Institutions (%) | 7.88% |
| Float | 55.01M |
Valuation Ratios
The trailing PE ratio is 16.73.
| PE Ratio | 16.73 |
| Forward PE | n/a |
| PS Ratio | 4.16 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 13.07 |
| P/OCF Ratio | 12.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.42, with an EV/FCF ratio of 11.74.
| EV / Earnings | 14.96 |
| EV / Sales | 3.74 |
| EV / EBITDA | 9.42 |
| EV / EBIT | 11.87 |
| EV / FCF | 11.74 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.11 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 0.97 |
| Interest Coverage | 82.26 |
Financial Efficiency
Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 10.02%.
| Return on Equity (ROE) | 15.40% |
| Return on Assets (ROA) | 9.08% |
| Return on Invested Capital (ROIC) | 10.02% |
| Return on Capital Employed (ROCE) | 16.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.95 |
Taxes
In the past 12 months, Bioteque has paid 140.56 million in taxes.
| Income Tax | 140.56M |
| Effective Tax Rate | 21.35% |
Stock Price Statistics
The stock price has decreased by -0.79% in the last 52 weeks. The beta is 0.12, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -0.79% |
| 50-Day Moving Average | 122.70 |
| 200-Day Moving Average | 120.40 |
| Relative Strength Index (RSI) | 50.67 |
| Average Volume (20 Days) | 66,016 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.07 billion and earned 517.86 million in profits. Earnings per share was 7.44.
| Revenue | 2.07B |
| Gross Profit | 914.79M |
| Operating Income | 652.96M |
| Pretax Income | 658.42M |
| Net Income | 517.86M |
| EBITDA | 807.29M |
| EBIT | 652.96M |
| Earnings Per Share (EPS) | 7.44 |
Balance Sheet
The company has 1.52 billion in cash and 638.34 million in debt, giving a net cash position of 878.46 million or 12.68 per share.
| Cash & Cash Equivalents | 1.52B |
| Total Debt | 638.34M |
| Net Cash | 878.46M |
| Net Cash Per Share | 12.68 |
| Equity (Book Value) | 3.44B |
| Book Value Per Share | 49.57 |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was 691.77 million and capital expenditures -31.65 million, giving a free cash flow of 660.12 million.
| Operating Cash Flow | 691.77M |
| Capital Expenditures | -31.65M |
| Free Cash Flow | 660.12M |
| FCF Per Share | 9.53 |
Margins
Gross margin is 44.14%, with operating and profit margins of 31.51% and 24.99%.
| Gross Margin | 44.14% |
| Operating Margin | 31.51% |
| Pretax Margin | 31.77% |
| Profit Margin | 24.99% |
| EBITDA Margin | 38.95% |
| EBIT Margin | 31.51% |
| FCF Margin | 31.85% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.02%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 4.02% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 66.90% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 3.93% |
| Earnings Yield | 6.00% |
| FCF Yield | 7.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 6.91 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.91 |
| Piotroski F-Score | 7 |